ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism

Tawulie, Dina; Jin, Lulu; Shang, Xin; Li, Yimei; Sun, Le; Xie, Haixue; Zhao, Jie; Liao, Jiabao; Zhu, Zhangzhi*; Cui, Huantian*; Wen, Weibo*广州中医药大学; 山东大学; 1
PHYTOMEDICINE2023-5DOI: 10.1016/j.phymed.2023.154733
7被引26阅读
引用收藏
分享

摘要

Background: Jiang-Tang-San-Huang (JTSH) pill, a traditional Chinese medicine (TCM) prescription, has long been applied to clinically treat type 2 diabetes mellitus (T2DM), while the underlying antidiabetic mechanism remains unclarified. Currently, it is believed that the interaction between intestinal microbiota and bile acids (BAs) metabolism mediates host metabolism and promotes T2DM. @@@ Purpose: To elucidate the underlying mechanisms of JTSH for treating T2DM with animal models. @@@ Methods: In this study, male SD rats received high-fat diet (HFD) and streptozotocin (STZ) injection to induce T2DM and were treated with different dosages (0.27, 0.54 and 1.08 g/kg) of JTSH pill for 4 weeks; metformin was given as a positive control. Alterations of gut microbiota and BA profiles in the distal ileum were assessed by 16S ribosomal RNA gene sequencing and ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), respectively. Additionally, we conducted quantitative Real Time-PCR and western blotting to determine the mRNA and protein expression levels of intestinal farnesoid X receptor (FXR), fibroblast growth factor 15 (FGF15), Takeda G-protein-coupled receptor 5 (TGR5) and glucagon-like peptide 1 (GLP-1) as well as hepatic cytochrome P450, family 7, subfamily a, poly-peptide 1 (CYP7A1) and cytochrome P450, family 8, subfamily b, poly-peptide 1 (CYP8B1), which are involved in BAs metabolism and enterohepatic circulation. @@@ Results: Here, the results revealed that JTSH treatment significantly ameliorated hyperglycaemia, insulin resistance (IR), hyperlipidaemia, and pathological changes in the pancreas, liver, kidney and intestine and reduced the serum levels of pro-inflammatory cytokines in T2DM model rats. 16S rRNA sequencing and UPLC-MS/MS showed that JTSH treatment could modulate gut microbiota dysbiosis by preferentially increasing bacteria (e.g., Bacteroides, Lactobacillus, Bifidobacterium) with bile-salt hydrolase (BSH) activity, which might in turn lead to the accumulation of ileal unconjugated BAs (e.g., CDCA, DCA) and further upregulate the intestinal FXR/FGF15 and TGR5/GLP-1 signaling pathways. @@@ Conclusion: The study demonstrated that JTSH treatment could alleviate T2DM by modulating the interaction between gut microbiota and BAs metabolism. These findings suggest that JTSH pill may serve as a promising oral therapeutic agent for T2DM.

学科与关键词

关键词
Type 2 diabetes mellitusJiang-Tang-San-Huang pillGut microbiotaBile acids metabolismFXR/FGF15 signalingTGR5/GLP-1 signaling
相关
加载中…
  • Tang-Ping-San Decoction Remodel Intestinal Flora and Barrier to Ameliorate Type 2 Diabetes Mellitus in Rodent Model
    Yin, Wen; Zhang, Si-Qi; Pang, Wen-Lin; Chen, Xiao-Jiao; Wen, Jing; Hou, Jiong; Wang, Cui; Song, Li-Yun; Qiu, Zhen-Ming; Liang, Peng-Tao; Yuan, Jia-Li; Yang, Zhong-Shan*; Bian, Yao*Diabetes Metabolic Syndrome and Obesity-Targets and Therapy, 2022, 15: 2563-2581.被引 5
  • Patient-Reported Outcomes Following the Use of Jiang Tang San Huang Tablets in Type 2 Diabetes Mellitus: A Retrospective Cohort Study in a Chinese Population
    Shao, Cui; Sun, Mengxue; Liu, Wanwen; Zhao, Shaoyang; Liu, Yang; Chen, Yuna; Liang, Shu-Nung; Yuan, Haoyu; Sui, Huacheng; Wang, Baohua*; Li, Saimei*DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2022, 15: 4023-4033.
  • Intervention effect of Potentilla discolor- Euonymus alatus on intestinal flora of type 2 diabetes mellitus rats
    He, S. -y.; Qiu, X. M.; Wang, Y. -q.; Su, Z. Q.; Zhang, B. -y.; Wen, Z.; Yang, Y. -f.; Xing, B. -f.; Hong, M.; Liao, R.*European Review for Medical and Pharmacological Sciences, 2022, 26(24): 9062-9071.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-05
卷期
第 113 卷
页码
154733
DOI
10.1016/j.phymed.2023.154733
语言
GERMAN
成果收录
SCIE
资助标注
National Natural Science Founda- tion of China [82174284]

作者

  • T

    Tawulie, Dina (第一作者)

    1 · guangzhou univ chinese med

  • J

    Jin, Lulu

    tianjin univ tradit chinese med

查看全部 11 位作者收起作者
  • S

    Shang, Xin

    1 · guangzhou univ chinese med

  • L

    Li, Yimei

    1 · guangzhou univ chinese med

  • S

    Sun, Le

    1 · guangzhou univ chinese med

  • X

    Xie, Haixue

  • Z

    Zhao, Jie

  • L

    Liao, Jiabao

  • Z

    Zhu, Zhangzhi (通讯)

    1 · guangzhou univ chinese med

  • C

    Cui, Huantian (通讯)

    shandong univ

  • W

    Wen, Weibo (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417